HMG-CoA Reductase Inhibitors, Other Lipid-Lowering Medication, Antiplatelet Therapy, and the Risk of Venous Thrombosis

Journal of Thrombosis and Haemostasis- United Kingdom

doi 10.1111/j.1538-7836.2008.03235.x

Full Text

Abstract

Available in

Categories

Date

April 1, 2009

Authors

A. S. RAMCHARAN

K. J. VAN STRALEN

A. K. MANTEL-TEEUWISSE

F. R. ROSENDAAL

C. J. M. DOGGEN

Publisher

Wiley

Related search

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine

English

HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients

JAMA - Journal of the American Medical Association

English

HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

English

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

Cardiovascular Medicine

English

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

English

Role of HMG-CoA Reductase Inhibitors With Curative Radiotherapy in Men With Prostate Cancer

Research and Reports in Urology

English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society

English

HMG CoA Reductase Inhibitors (Statins) for People With Chronic Kidney Disease Not Requiring Dialysis

Cochrane Database of Systematic Reviews

English

Features of the HMG 1 Subfamily of Genes Encoding HMG-CoA Reductase in Potato

Plant Molecular Biology

English